Pembrolizumab for Early Triple-Negative Breast Cancer. Cetin B, Gumusay O. N Engl J Med 2020;382:e108.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cetin B, Gumusay O. Pembrolizumab for Early Triple-Negative Breast Cancer. N Engl J Med 2020;382:e108.
PMID: 32579834